{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:58:55Z","timestamp":1762541935871},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,7,1]]},"DOI":"10.1093\/neuonc\/1.3.196","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T19:59:49Z","timestamp":1283284789000},"page":"196-203","source":"Crossref","is-referenced-by-count":13,"title":["The consequences of treatment and disease in patients with primary CNS\nnon-Hodgkin's lymphoma: Cognitive function and performance status"],"prefix":"10.1093","volume":"1","author":[{"given":"Brian P.","family":"O'Neill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiao-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith R.","family":"O'Fallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph P.","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Earle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Krigel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,7,1]]},"reference":[{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Abrey, L.E., DeAngelis, L.M., and Yahalom, J. (1998)\nLong-term survival in primary CNS lymphoma. J. Clin.\nOncol.16,859\n-863.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Allen, J.C., Rosen, G., Mehta, B.M., and Horten, B.\n(1980) Leukoencephalopathy following high-dose IV methotrexate\nchemotherapy with leukovorin rescue. Cancer Treat.\nRep.64,1261\n-1273.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Blay, J.Y., Conroy, T., Chevreau, C., Thyss, A., Quesnel, N.,\nEghbali, H., Bouabdallah, R., Coiffier, B., Wagner, J.P., Le Mevel, A.,\nDramais-Marcel, D., Baumelou, E., Chauvin, F., and Biron, P.\n(1998) High-dose methotrexate for the treatment of primary\ncerebral lymphomas: Analysis of survival and late neurologic toxicity in a\nretrospective series. J. Clin. Oncol.16,864\n-871.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Brada, M., Dearnaley, D., Horwich, A., and Bloom, H.J.\n(1990) Management of primary cerebral lymphoma with initial\nchemotherapy: Preliminary results and comparison with patients treated with\nradiotherapy alone. Int. J. Radiat. Oncol. Biol. Phys.18,787\n-792.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Cote, T.R., Manna, A., Hardy, C.R., Yellin, F.J., and Hartge, P.\n(1996) Epidemiology of brain lymphoma among people with or\nwithout acquired immunodeficiency syndrome. J. Natl. Cancer.\nInst.88,675\n-679.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Crossen, J.R., Garwood, D., Glatstein, E., and Neuwelt, E.A.\n(1994) Neurobehavioral sequalae of cranial irradiation in adults:\nA review of radiation-induced encephalopathy. J. Clin.\nOncol.12,627\n-642.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"DeAngelis, L.M., Delattre, J.Y., and Posner, J.B.\n(1989) Radiation-induced dementia in patients cured of\nmetastases. Neurology39,789\n-796.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"DeAngelis, L.M., Yahalom, J., Heinemann, M.H., Cirrincione, C.,\nThaler, H.T., and Krol, G. (1990) Primary CNS lymphoma: Combined\ntreatment with chemotherapy and radiotherapy.\nNeurology40,80\n-86.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Eby, N.L., Grufferman, S., Flannelly, C.M., Schold, S.C., Jr.,\nVogel, F.S., and Burger, P.C. (1988) Increasing incidence of\nprimary brain lymphoma in the U.S. Cancer62,2461\n-2465.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M.,\nMize, E.M., Glock, J.H., Coltman, C.A., Jr., and Miller, T.P.\n(1993) Comparison of a standard regimen (CHOP) with three\nintensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.\nN. Engl. J. Med.328,1002\n-1006.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Folstein, M.F., Folstein, S.E., and McHugh, P.R.\n(1975) \u201cMini-mental state.\u201d A practical method for\ngrading the cognitive state of patients for the clinician. J.\nPsychiatr. Res.12,189\n-198.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Freilich, R.J., Delattre, J.Y., Monjour, A., and DeAngelis, L.M.\n(1996) Chemotherapy without radiation therapy as initial\ntreatment for primary CNS lymphoma in older patients.\nNeurology46,435\n-439.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Frick, J.C., Hansen, R.M., Anderson, T., and Ritch, P.S.\n(1986) Successful high-dose intravenous cytarabine treatment of\nparenchymal brain involvement from malignant lymphoma. Arch.\nIntern. Med.146,791\n-792.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Glass, J., Gruber, M.L., Cher, L., and Hochberg, F.H.\n(1994) Preirradiation methotrexate chemotherapy of primary\ncentral nervous system lymphoma: Long-term outcome. J.\nNeurosurg.81,188\n-195.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Henry, J.M., Heffner, R.R., Jr., Dillard, S.H., Earle, K.M., and\nDavis, R.L. (1974) Primary malignant lymphomas of the central\nnervous system. Cancer34,1293\n-1302.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Hochberg, F.H., and Pruitt, A. (1980) Assumptions in\nthe radiotherapy of glioblastoma. Neurology30,907\n-911.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Hochberg, F.H., and Slotnick, B. (1980)\nNeuropsychologic impairment in astrocytoma survivors.\nNeurology30,172\n-177.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Kaplan, E.L., and Meier, P. (1958) Nonparametric\nestimation from incomplete observations. J. Am. Stat.\nAssoc.53,457\n-481.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"MacDonald, D.R., Cascino, T.L., Schold, S.C., Jr., and Cairncross,\nJ.G. (1990) Response criteria for phase II studies of\nsupratentorial malignant glioma. J. Clin. Oncol.8,1277\n-1280.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Mantel, N. (1966) Evaluation of survival data and two\nnew rank order statistics arising in its consideration. Cancer\nChemother. Rep. Pt. 150,163\n-170.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Murray, K.J., Nelson, D.F., Scott, C., Fischbach, A.J., Porter, A.,\nFarnan, N., and Curran, W.J., Jr. (1995) Quality-adjusted\nsurvival analysis of malignant glioma. Patients treated with twice-daily\nradiation (RT) and carmustine: A report of Radiation Therapy Oncology Group\n(RTOG) 83\u201302. Int. J. Radiat. Oncol. Biol. Phys.31,453\n-459.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Nelson, D.F., Martz, K.L., Bonner, H., Nelson, J.S., Newall, J.,\nKerman, H.D., Thomson, J.W., and Murray, K.J. (1992)\nNon-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation\ntherapy improve survival? Report on a prospective trial by the Radiation\nTherapy Oncology Group (RTOG): RTOG 8315. Int. J. Radiat. Oncol.\nBiol. Phys.23,9\n-17.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Nesbitt, J.C., Lee, J.S., Komaki, R., and Roth, J.A.\n(1997) Cancer of the lung. In: Holland, J.F., Bast, R.C., Jr.,\nMorton, D.L., Frei, E., III, Kufe, D.W., Weichselbaum, R.R. (Eds.),Cancer Medicine. Fourth edition\n. Philadelphia:\nWilliams and Wilkins. pp. 1723-1803.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Neuwelt, E.A., Goldman, D.L., Dahlborg, S.A., Crossen, J., Ramsey,\nF., Roman-Goldstein, S., Braziel, R., and Dana, B. (1991) Primary\nCNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged\nsurvival and preservation of cognitve function. J. Clin.\nOncol.9,1580\n-1590.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"O'Neill, B.P., O'Fallon, J.R., Earle, J.D., Colgan, J.P., Brown,\nL.D., and Krigel, R.L. (1995) Primary central nervous system\nnon-Hodgkin's lymphoma: Survival advantages with combined initial therapy?\nInt. J. Radiat. Oncol. Biol. Phys.33,663\n-673.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"O'Neill, B.P., and Illig, J. (1989) Primary central\nnervous system lymphoma. Mayo Clin. Proc.64,1005\n-1020.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"O'Neill, B.P., Tomlinson, F.H., O'Fallon, J.R., Scherthauer, B.W.,\nKurtin, P.J., and O'Neill, D.B. (1993) The continuing increase of\nprimary central nervous system non-Hodgkin's lymphoma (PCNSL). Ann.\nNeurol.34,313\n.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Poisson, M., Hauw, J.J., Pouillart, P., Bataini, J.P., Mashaly, R.,\nPertuiset, B.F., and Metzger, J. (1979) Malignant gliomas treated\nafter surgery by combination chemotherapy and delayed radiation therapy. Part\nII. Tolerance to irradiation after chemotherapy. Acta. Neurochir.\n(Wien)51,27\n-42.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Schiffer, D., Chio, A., Giordana, M.T., Novero, D., Palestro, G.,\nSoffietti, R., and Vasario, E. (1987) Primary lymphomas of the\nbrain: A clinicopathologic review of 37 cases. Tumori73,585\n-592,.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Shibamoto Y., Tsutsui, K., Dodo, Y., Yamabe, H., Shima, N., and\nAbe, M. (1990) Improved survival rate in primary intracranial\nlymphoma treated by high-dose radiation and systemic\nvincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy.\nCancer65,1907\n-1912.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"So, N.K., O'Neill, B.P., Frytak, S., Eagan, R.T., Earnest, F., IV,\nand Lee, R.E. (1987) Delayed leukoencephalopathy in survivors\nwith small cell lung cancer. Neurology37,1198\n-1201.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Taylor, B.V., Buckner, J.C., Cascino, T.L., O'Fallon, J.R.,\nSchaefer, P.L., Dinapoli, R.P., and Schomberg, P. (1998) Effects\nof radiation and chemotherapy on cognitive function in patients with\nhigh-grade glioma. J. Clin. Oncol.16,2195\n-2201.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Tomlinson, F.H., Kurtin, P.J., Suman, V.J., Scheithauer, B.W.,\nO'Fallon, J.R., Delly, P.J., Jack, C.R., Jr., and O'Neill, B.P.\n(1995) Primary intracerebral malignant lymphoma: A\nclinicopathological study of 89 patients. J.\nNeurosurg.82,558\n-566.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Tondini, C., Zanini, M., Lombardi, F., Bengala, C., Rocca, A.,\nGiardini, R., Buzzoni, R., Valagussa, P., and Bonadonna, G.\n(1993) Combined modality treatment with primary CHOP chemotherapy\nfollowed by locoregional irradiation in stage I or II histologically\naggressive non-Hodgkin's lymphomas. J. Clin. Oncol.11,720\n-725.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Trojanowski, T., Peszynski, J., Turowski, K., Markiewicz, P.,\nGoscinski, I., Bielawski, A., Bendarzewska, B., Szymona, J., Dabrowska, A.,\nand Lopatkiewicz, J. (1989) Quality of survival of patients with\nbrain gliomas treated with postoperative CCNU and radiation therapy.\nJ. Neurosurg.70,18\n-23.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Weitzner, M.A., Meyers, C.A., and Byrne, K. (1996)\nPsychosocial functioning and quality of life in patients with primary brain\ntumors. J. Neurosurg.84, 29-34.","DOI":"10.2307\/3001968"},{"key":"key\n\t\t\t\t20171013042035_","doi-asserted-by":"crossref","unstructured":"Wilcoxon, F. (1945) Individual comparisons by ranking\nmethods. Biometrics1,80\n-83.","DOI":"10.2307\/3001968"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/1\/3\/196\/13065623\/p196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T08:28:14Z","timestamp":1507883294000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article\/1\/3\/196\/1063283\/The-consequences-of-treatment-and-disease-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,1]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,7,1]]},"published-print":{"date-parts":[[1999,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/1.3.196","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published-other":{"date-parts":[[1999,7]]},"published":{"date-parts":[[1999,7,1]]}}}